Shoulder Innovations settles patent dispute with Catalyst OrthoScience

Shoulder Innovations, Inc. (NYSE: SI) announced it has reached a settlement agreement with Catalyst OrthoScience Inc. to resolve all outstanding patent litigation between the two companies, according to a press release dated Sept. 8, 2026.

The financial terms of the settlement were not disclosed.

"We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. "Protecting our intellectual property is fundamental to ensuring that the investments we make in innovation continue to benefit Shoulder Innovations stakeholders, particularly including surgeons and patients."

Shoulder Innovations describes itself as a commercial-stage medical technology company focused on the shoulder surgical care market, offering implant systems for shoulder arthroplasty.

You May Also Be Interested In

• Bank of America adds two former CEOs to its board
• Santacruz Silver posts Q3 2026 output of 1.5M silver ounces
• Goldman Sachs on Meta Platforms Inc. (META): 'We expect investors to have an initial positive reaction'